Pri-Med Phoenix | Regional CME/CE Conference

Description

This educational program addresses the implications of leaving residual symptoms untreated in patients with major depressive disorder (MDD) receiving antidepressant therapy alone. We will review the treatment challenges associated with unresolved symptoms and evaluate the potential role of adding an atypical antipsychotic as an adjunctive strategy. Clinical trial evidence supporting an adjunctive therapy will be reviewed to guide treatment planning for patients with MDD.